Alzinova: Completes Preclinical Humanization of ALZ-201

Research Note

2022-01-21

10:00

Redeye is encouraged by the news that Alzinova has successfully completed the humanization work, and selected a humanized lead candidate, of its monoclonal antibody ALZ-201.

KS

Kevin Sule

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.